243 related articles for article (PubMed ID: 10193765)
21. Evidence for a M(1) muscarinic receptor on the endothelium of human pulmonary veins.
Walch L; Gascard JP; Dulmet E; Brink C; Norel X
Br J Pharmacol; 2000 May; 130(1):73-8. PubMed ID: 10781000
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the prostanoid receptors mediating constriction and relaxation of human isolated uterine artery.
Baxter GS; Clayton JK; Coleman RA; Marshall K; Sangha R; Senior J
Br J Pharmacol; 1995 Sep; 116(1):1692-6. PubMed ID: 8564239
[TBL] [Abstract][Full Text] [Related]
23. A novel inhibitory prostanoid receptor in piglet saphenous vein.
Coleman RA; Grix SP; Head SA; Louttit JB; Mallett A; Sheldrick RL
Prostaglandins; 1994 Feb; 47(2):151-68. PubMed ID: 8016385
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the inhibitory prostanoid receptors on human neutrophils.
Wheeldon A; Vardey CJ
Br J Pharmacol; 1993 Apr; 108(4):1051-4. PubMed ID: 8387383
[TBL] [Abstract][Full Text] [Related]
25. Differential peristaltic motor effects of prostanoid (DP, EP, IP, TP) and leukotriene receptor agonists in the guinea-pig isolated small intestine.
Shahbazian A; Heinemann A; Peskar BA; Holzer P
Br J Pharmacol; 2002 Dec; 137(7):1047-54. PubMed ID: 12429577
[TBL] [Abstract][Full Text] [Related]
26. Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery.
Qian YM; Jones RL; Chan KM; Stock AI; Ho JK
Br J Pharmacol; 1994 Oct; 113(2):369-74. PubMed ID: 7834185
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder.
Palea S; Toson G; Pietra C; Trist DG; Artibani W; Romano O; Corsi M
Br J Pharmacol; 1998 Jul; 124(5):865-72. PubMed ID: 9692770
[TBL] [Abstract][Full Text] [Related]
28. Modulation of noradrenaline release from the sympathetic nerves of the human saphenous vein and pulmonary artery by presynaptic EP3- and DP-receptors.
Molderings GJ; Colling E; Likungu J; Jakschik J; Göthert M
Br J Pharmacol; 1994 Mar; 111(3):733-8. PubMed ID: 8019753
[TBL] [Abstract][Full Text] [Related]
29. In vitro characterization of prostanoid FP-, DP-, IP- and TP-receptors on the non-pregnant human myometrium.
Senior J; Sangha R; Baxter GS; Marshall K; Clayton JK
Br J Pharmacol; 1992 Sep; 107(1):215-21. PubMed ID: 1422574
[TBL] [Abstract][Full Text] [Related]
30. In vitro characterization of prostanoid receptors on human myometrium at term pregnancy.
Senior J; Marshall K; Sangha R; Clayton JK
Br J Pharmacol; 1993 Feb; 108(2):501-6. PubMed ID: 8448599
[TBL] [Abstract][Full Text] [Related]
31. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation.
Kay LJ; Yeo WW; Peachell PT
Br J Pharmacol; 2006 Apr; 147(7):707-13. PubMed ID: 16432506
[TBL] [Abstract][Full Text] [Related]
32. Interaction of BW A868C, a prostanoid DP-receptor antagonist, with two receptor subtypes in the rabbit isolated saphenous vein.
Lydford SJ; McKechnie KC; Leff P
Prostaglandins; 1996 Aug; 52(2):125-39. PubMed ID: 8880898
[TBL] [Abstract][Full Text] [Related]
33. Prostanoid receptors involved in regulation of the beating rate of neonatal rat cardiomyocytes.
Mechiche H; Grassin-Delyle S; Robinet A; Nazeyrollas P; Devillier P
PLoS One; 2012; 7(9):e45273. PubMed ID: 22984630
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological and functional characterization of novel EP and DP receptor agonists: DP1 receptor mediates penile erection in multiple species.
Brugger N; Kim NN; Araldi GL; Traish AM; Palmer SS
J Sex Med; 2008 Feb; 5(2):344-56. PubMed ID: 18047485
[TBL] [Abstract][Full Text] [Related]
35. Prostanoid action on the human pulmonary vascular system.
Jones RL; Qian Y; Wong HN; Chan H; Yim AP
Clin Exp Pharmacol Physiol; 1997 Dec; 24(12):969-72. PubMed ID: 9406667
[TBL] [Abstract][Full Text] [Related]
36. Role of prostanoid IP and EP receptors in mediating vasorelaxant responses to PGI2 analogues in rat tail artery: Evidence for Gi/o modulation via EP3 receptors.
Orie NN; Clapp LH
Eur J Pharmacol; 2011 Mar; 654(3):258-65. PubMed ID: 21185823
[TBL] [Abstract][Full Text] [Related]
37. Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea-pig ileum.
Lawrence RA; Jones RL; Wilson NH
Br J Pharmacol; 1992 Feb; 105(2):271-8. PubMed ID: 1559125
[TBL] [Abstract][Full Text] [Related]
38. Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.
Säfholm J; Manson ML; Bood J; Delin I; Orre AC; Bergman P; Al-Ameri M; Dahlén SE; Adner M
J Allergy Clin Immunol; 2015 Nov; 136(5):1232-9.e1. PubMed ID: 25962903
[TBL] [Abstract][Full Text] [Related]
39. Differential actions of the prostacyclin analogues treprostinil and iloprost and the selexipag metabolite, MRE-269 (ACT-333679) in rat small pulmonary arteries and veins.
Orie NN; Ledwozyw A; Williams DJ; Whittle BJ; Clapp LH
Prostaglandins Other Lipid Mediat; 2013 Oct; 106():1-7. PubMed ID: 23872196
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the prostanoid receptor types involved in mediating calcitonin gene-related peptide release from cultured rat trigeminal neurones.
Jenkins DW; Feniuk W; Humphrey PP
Br J Pharmacol; 2001 Nov; 134(6):1296-302. PubMed ID: 11704650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]